Literature DB >> 2283514

Neuropsychological deficits in myotonic muscular dystrophy.

P Malloy1, S K Mishra, S H Adler.   

Abstract

Twenty patients with myotonic muscular dystrophy (MMD) were compared with twenty controls on a battery of standardised neuropsychiological tests measuring motor and cognitive functions. The MMD patients performed significantly poorer on both motor and cognitive tests, particularly those assessing spatial functions. Although both motor and cognitive scores were correlated with age, significant diagnostic group by age interactions were present only for the motor measures. Therefore, while motor deficits in MMD may progress with ageing, cognitive deficits are mainly developmental and relatively stable.

Entities:  

Mesh:

Year:  1990        PMID: 2283514      PMCID: PMC488288          DOI: 10.1136/jnnp.53.11.1011

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Psychopathology: a primary feature of myotonic dystrophy.

Authors:  P G Ambrosini; H G Nurnberg
Journal:  Psychosomatics       Date:  1979-06       Impact factor: 2.386

2.  Evaluation of information-processing speed and neuropsychological functioning in patients with myotonic dystrophy.

Authors:  D T Stuss; M H Kates; C A Poirier; D Hylton; P Humphreys; D Keene; G Laflèche
Journal:  J Clin Exp Neuropsychol       Date:  1987-04       Impact factor: 2.475

3.  Neuropsychological findings in myotonic dystrophy.

Authors:  J B Woodward; R K Heaton; D B Simon; S P Ringel
Journal:  J Clin Neuropsychol       Date:  1982-12

4.  Cognitive and personality function in myotonic muscular dystrophy.

Authors:  T D Bird; C Follett; E Griep
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

5.  Intellectual and cognitive function in adults with myotonic muscular dystrophy.

Authors:  M M Portwood; J J Wicks; J S Lieberman; M J Duveneck
Journal:  Arch Phys Med Rehabil       Date:  1986-05       Impact factor: 3.966

6.  Psychometric evaluation in myotonic muscular dystrophy.

Authors:  M M Portwood; J J Wicks; J S Lieberman; W M Fowler
Journal:  Arch Phys Med Rehabil       Date:  1984-09       Impact factor: 3.966

  6 in total
  7 in total

1.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

2.  Apathy and hypersomnia are common features of myotonic dystrophy.

Authors:  J S Rubinsztein; D C Rubinsztein; S Goodburn; A J Holland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

3.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

Review 4.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

5.  Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Authors:  Stéphane Jean; Louis Richer; Luc Laberge; Jean Mathieu
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

6.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

7.  Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Authors:  Garazi Labayru; Irati Arenzana; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga A
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.